文献速递临床试验与 GCP

沉浸式虚拟现实作为子宫输卵管造影镇痛手段:随机对照试验研究方案

Immersive virtual reality as analgesia for women during hysterosalpingography: study protocol for a randomized controlled trial.
PubMed 文献 · Trials · 2020-01-20

本研究为单中心平行组随机对照试验方案,计划纳入200例拟行子宫输卵管造影(HSG)的女性,按1:1随机分为沉浸式虚拟现实(VR)组与空白对照组,评价VR在HSG过程中的镇痛效果。主要结局为HSG期间最严重疼痛的视觉模拟量表(VAS)评分,次要结局涵盖情感与认知疼痛、焦虑、术后15分钟内最严重疼痛、满意度与接受度、生理参数、不良事件及HSG结果等。

要点

  • VR组在常规护理基础上接受沉浸式VR干预,对照组仅接受常规护理。
  • 主要结局为HSG期间最严重疼痛的VAS评分。
  • 结局在基线、HSG后即刻及HSG后15分钟三个时点评估。

核心结论

  • 本试验旨在评估HSG过程中VR分散注意力的镇痛效果,并将提供该疗法可行性与安全性的数据。

研究设计与样本

  • 单中心、平行组随机对照试验,在银川市妇幼保健院放射科开展。
  • 计划纳入200例拟行HSG的参与者,按1:1随机分为VR组与空白对照组。
  • VR组接受常规护理加沉浸式VR干预,空白对照组仅接受常规护理。
  • 结局在基线、HSG后即刻及HSG后15分钟三个时点监测。

关键数值与推荐

  • 主要结局为HSG期间最严重疼痛的VAS评分。
  • 次要结局包括HSG期间的情感疼痛、认知疼痛与焦虑,HSG后15分钟内最严重疼痛,患者对疼痛管理的满意度与接受度,生理参数,不良事件,HSG结果,以及VR系统沉浸感评分(仅VR组)。

临床怎么用

  • 本研究关注一种操作简单、无创且低成本的HSG镇痛方式,结果可为VR分散注意力疗法在HSG中的可行性提供依据。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Hysterosalpingography (HSG) is an accepted radiologic diagnostic modality for initial infertility workup, and is generally considered uncomfortable and painful. However, the management of pain related to HSG remains inefficient. As an emerging nonpharmacologic and noninvasive pain control strategy, virtual reality (VR) distraction has been successfully used in areas such as burns, blunt force trauma, hospital-based needle procedures, dental/periodontal procedures, and urological endoscopy patients. This study aims to evaluate the analgesic effect of VR during HSG. METHODS/DESIGN: A single-center, parallel-group, randomized controlled trial will be carried out in the Radiology Department of Yinchuan Women and Children Healthcare Hospital, Yinchuan. A total of 200 participants who are scheduled for HSG will be enrolled in this study. The participants will be randomized (1:1) into two groups: a VR group and a blank control group. The VR group will receive routine care plus immersive VR intervention and the blank control group will receive routine care. Outcomes will be monitored at baseline, immediately after HSG and 15 min after HSG for each group. The primary outcome is the worst pain score during HSG by a visual analog scale (VAS). The secondary outcomes include: affective pain, cognitive pain, and anxiety during the HSG procedure; worst pain within 15 min after HSG; patient satisfaction and acceptance with pain management; physiological parameters; adverse effects; HSG results; and immersion perception score of the VR system (for the VR condition only). DISCUSSION: This study will focus on exploring a simply operated, noninvasive and low-cost analgesia during the HSG procedure. The results of this trial will provide data on the feasibility and safety of VR distraction therapy during HSG. TRIAL REGISTRATION: Chinese Clinical Trial Register, ChiCTR1900021342. Registered on 16 February 2019.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Wang YL, Gao HX, Wang JS, et al. Immersive virtual reality as analgesia for women during hysterosalpingography: study protocol for a randomized controlled trial. Trials. 2020. PMID: 31959220. doi:10.1186/s13063-019-4023-y

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。